# Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia

> **NCT00017108** · PHASE3 · UNKNOWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC**

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** chlorambucil
- **DRUG:** cyclophosphamide
- **DRUG:** fludarabine phosphate

## Key facts

- **NCT ID:** NCT00017108
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017108, "Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00017108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*